CN102579763A - 治疗烧烫伤的外用中药组合物 - Google Patents
治疗烧烫伤的外用中药组合物 Download PDFInfo
- Publication number
- CN102579763A CN102579763A CN2012100630469A CN201210063046A CN102579763A CN 102579763 A CN102579763 A CN 102579763A CN 2012100630469 A CN2012100630469 A CN 2012100630469A CN 201210063046 A CN201210063046 A CN 201210063046A CN 102579763 A CN102579763 A CN 102579763A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine composition
- scalds
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 39
- 206010053615 Thermal burn Diseases 0.000 title claims abstract description 27
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229940079593 drug Drugs 0.000 claims abstract description 19
- 229940056582 human hair preparation Drugs 0.000 claims abstract description 14
- 239000000292 calcium oxide Substances 0.000 claims abstract description 13
- 235000012255 calcium oxide Nutrition 0.000 claims abstract description 13
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims abstract description 12
- 229940097275 indigo Drugs 0.000 claims abstract description 12
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims abstract description 12
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 8
- 241000959626 Calvatia Species 0.000 claims description 14
- 239000009286 sanguis draxonis Substances 0.000 claims description 10
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims description 9
- 241000545442 Radix Species 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 4
- 239000002674 ointment Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 206010052428 Wound Diseases 0.000 abstract description 23
- 208000027418 Wounds and injury Diseases 0.000 abstract description 23
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 5
- 206010039509 Scab Diseases 0.000 abstract description 4
- 239000012530 fluid Substances 0.000 abstract description 4
- 230000003385 bacteriostatic effect Effects 0.000 abstract description 3
- 230000007812 deficiency Effects 0.000 abstract description 3
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- 244000170916 Paeonia officinalis Species 0.000 abstract description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract description 2
- 229910052956 cinnabar Inorganic materials 0.000 abstract description 2
- 230000012010 growth Effects 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 244000047855 Acalypha wilkesiana Species 0.000 abstract 1
- 241000130781 Arnebia Species 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 241000099774 Cuscuta salina Species 0.000 abstract 1
- 241000133231 Marshallia caespitosa Species 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- WEMFUFMJQFVTSW-UHFFFAOYSA-N compositin Natural products CC=C(C)C(=O)OC1CC(O)C2(C)COC3C2C1(C)C1CCC2(C)C(CC=C2C1(C)C3OC(=O)C(C)=CC)c1ccoc1 WEMFUFMJQFVTSW-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 24
- 239000008280 blood Substances 0.000 description 24
- -1 stilbene glycoside Chemical class 0.000 description 16
- 230000000694 effects Effects 0.000 description 14
- 230000036407 pain Effects 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 10
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 9
- CRDNMYFJWFXOCH-YPKPFQOOSA-N (3z)-3-(3-oxo-1h-indol-2-ylidene)-1h-indol-2-one Chemical compound N/1C2=CC=CC=C2C(=O)C\1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-YPKPFQOOSA-N 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 229930182470 glycoside Natural products 0.000 description 6
- 230000023597 hemostasis Effects 0.000 description 6
- 241000207929 Scutellaria Species 0.000 description 5
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000005711 Benzoic acid Substances 0.000 description 4
- DXENDDMPDZMHSQ-UHFFFAOYSA-N Candinine Chemical compound C12=NC3=CC=CC=C3C(=O)N1C1=CC=CC=C1C2=C1C(=O)C2=CC=CC=C2N1 DXENDDMPDZMHSQ-UHFFFAOYSA-N 0.000 description 4
- CRDNMYFJWFXOCH-BUHFOSPRSA-N Couroupitine B Natural products N\1C2=CC=CC=C2C(=O)C/1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-BUHFOSPRSA-N 0.000 description 4
- 229920000296 Glucogallin Polymers 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 235000010233 benzoic acid Nutrition 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- CRDNMYFJWFXOCH-UHFFFAOYSA-N isoindigotin Natural products N1C2=CC=CC=C2C(=O)C1=C1C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-UHFFFAOYSA-N 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 150000004056 anthraquinones Chemical class 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- XKVWLLRDBHAWBL-UHFFFAOYSA-N imperatorin Natural products CC(=CCOc1c2OCCc2cc3C=CC(=O)Oc13)C XKVWLLRDBHAWBL-UHFFFAOYSA-N 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- NSGZEHPFOUCUHD-UHFFFAOYSA-N 1,3-dihydroxy-9,10-dioxoanthracene-2-carbaldehyde Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=C(O)C(C=O)=C2O NSGZEHPFOUCUHD-UHFFFAOYSA-N 0.000 description 2
- CZODYZFOLUNSFR-UHFFFAOYSA-N 1-hydroxy-2-methyl-9,10-anthraquinone Chemical compound C1=CC=C2C(=O)C3=C(O)C(C)=CC=C3C(=O)C2=C1 CZODYZFOLUNSFR-UHFFFAOYSA-N 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- 241000125175 Angelica Species 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010009346 Clonus Diseases 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- KEQFTVQCIQJIQW-UHFFFAOYSA-N N-Phenyl-2-naphthylamine Chemical compound C=1C=C2C=CC=CC2=CC=1NC1=CC=CC=C1 KEQFTVQCIQJIQW-UHFFFAOYSA-N 0.000 description 2
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- KJGPBYUQZLUKLL-UHFFFAOYSA-N afrormosin Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O)=C(OC)C=C2C1=O KJGPBYUQZLUKLL-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 2
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 2
- 229940093265 berberine Drugs 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- ZZIALNLLNHEQPJ-UHFFFAOYSA-N coumestrol Chemical compound C1=C(O)C=CC2=C1OC(=O)C1=C2OC2=CC(O)=CC=C12 ZZIALNLLNHEQPJ-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 2
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 2
- 238000001804 debridement Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- JXDYKVIHCLTXOP-UHFFFAOYSA-N isatin Chemical compound C1=CC=C2C(=O)C(=O)NC2=C1 JXDYKVIHCLTXOP-UHFFFAOYSA-N 0.000 description 2
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- IGGUPRCHHJZPBS-UHFFFAOYSA-N nonacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCC IGGUPRCHHJZPBS-UHFFFAOYSA-N 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000003836 peripheral circulation Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- KQMVAGISDHMXJJ-UHFFFAOYSA-N prunetin Chemical compound C=1C(OC)=CC(O)=C(C2=O)C=1OC=C2C1=CC=C(O)C=C1 KQMVAGISDHMXJJ-UHFFFAOYSA-N 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- BBNQQADTFFCFGB-UHFFFAOYSA-N purpurin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC(O)=C3C(=O)C2=C1 BBNQQADTFFCFGB-UHFFFAOYSA-N 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 208000013223 septicemia Diseases 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 210000003905 vulva Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- WPWWKBNOXTZDQJ-UHFFFAOYSA-N xanthopurpurin Chemical compound C1=CC=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 WPWWKBNOXTZDQJ-UHFFFAOYSA-N 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- KAZSKMJFUPEHHW-UHFFFAOYSA-N (2E)-3-[5-(1,1-dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hdyroxyphenyl)-2-propen-1-one Natural products COC1=CC(O)=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-UHFFFAOYSA-N 0.000 description 1
- YDZWHGJRWMQCDP-NKILCQAGSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-8a-carboxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3-hydroxy-4-[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-[(2s,3r,4 Chemical compound O([C@H]1[C@H](O)[C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CCC(C[C@H]14)(C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O YDZWHGJRWMQCDP-NKILCQAGSA-N 0.000 description 1
- LDRFVNKBORCKQS-UHFFFAOYSA-N (4-carboxyphenyl)-cyanoimino-oxidoazanium Chemical compound OC(=O)C1=CC=C([N+]([O-])=NC#N)C=C1 LDRFVNKBORCKQS-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- GSNCQSIZHAMPRE-UHFFFAOYSA-N 1-(2-oxo-3H-indol-1-yl)-3H-indol-2-one Chemical compound O=C1CC2=CC=CC=C2N1N1C2=CC=CC=C2CC1=O GSNCQSIZHAMPRE-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- ZPSAEGUNYMEKBP-UHFFFAOYSA-N 5-Isopentenyloxy-psoralen Natural products CC(C)C=COc1c2C=CC(=O)Oc2cc3occc13 ZPSAEGUNYMEKBP-UHFFFAOYSA-N 0.000 description 1
- LATYEZNGPQKAIK-UHFFFAOYSA-N 6'-O-benzoylpaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- QQUHMASGPODSIW-UHFFFAOYSA-N Albiflorin Natural products C=1C=CC=CC=1C(=O)OCC12C(=O)OC3(C)CC(O)C1CC32OC1OC(CO)C(O)C(O)C1O QQUHMASGPODSIW-UHFFFAOYSA-N 0.000 description 1
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 description 1
- BEYIWVKWKJROGZ-UHFFFAOYSA-N Alloimperatorin Natural products O1C(=O)C=CC2=C1C(O)=C1OC=CC1=C2OCC=C(C)C BEYIWVKWKJROGZ-UHFFFAOYSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- LATYEZNGPQKAIK-HRCYFWENSA-N Benzoylpaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(=O)C=2C=CC=CC=2)O1)O)C)OC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-HRCYFWENSA-N 0.000 description 1
- GYFSYEVKFOOLFZ-UHFFFAOYSA-N Berberrubine Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(O)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 GYFSYEVKFOOLFZ-UHFFFAOYSA-N 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000959628 Calvatia gigantea Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 244000132059 Carica parviflora Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- XDVZNDLANFJOQR-UHFFFAOYSA-N Coptisine Natural products O=Cc1c2OCOc2ccc1C=C3/NCCc4cc5OCOc5cc34 XDVZNDLANFJOQR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010014568 Empyema Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000334154 Isatis tinctoria Species 0.000 description 1
- IGWDEVSBEKYORK-UHFFFAOYSA-N Isoimperatorin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)C IGWDEVSBEKYORK-UHFFFAOYSA-N 0.000 description 1
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 1
- MXTLAHSTUOXGQF-UHFFFAOYSA-O Jatrorrhizine Chemical compound COC1=CC=C2C=C3C(C=C(C(=C4)O)OC)=C4CC[N+]3=CC2=C1OC MXTLAHSTUOXGQF-UHFFFAOYSA-O 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- JGWYMAUEOSXSLU-UHFFFAOYSA-N Lactiflorin Natural products CC12CC(=O)C3CC(COC(=O)c4ccccc4)(C3O1)C25OC6OC(CO)C(O)C(O)C6O5 JGWYMAUEOSXSLU-UHFFFAOYSA-N 0.000 description 1
- 101710094902 Legumin Proteins 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- KAZSKMJFUPEHHW-DHZHZOJOSA-N Licochalcone A Chemical compound COC1=CC(O)=C(C(C)(C)C=C)C=C1\C=C\C(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-DHZHZOJOSA-N 0.000 description 1
- IUCVKTHEUWACFB-UHFFFAOYSA-N Licochalcone A Natural products COC1=CC=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 IUCVKTHEUWACFB-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- 241000222066 Lycoperdon pyriforme Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000010624 Medicago sativa Nutrition 0.000 description 1
- KGGUASRIGLRPAX-UHFFFAOYSA-N Meranzin hydrate Natural products C1=CC(=O)OC2=C(CC(O)C(C)(C)O)C(OC)=CC=C21 KGGUASRIGLRPAX-UHFFFAOYSA-N 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- XQWFHGOIUZFQPJ-USTPAGJBSA-N Neoisoliquiritigenin Natural products O=C(/C=C/c1ccc(O)cc1)c1c(O)cc(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O2)cc1 XQWFHGOIUZFQPJ-USTPAGJBSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-LXGDFETPSA-N Neoisoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC=C1C(=O)\C=C\C1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-LXGDFETPSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-UHFFFAOYSA-N Neoisoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1O)=CC=C1C(=O)C=CC1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-UHFFFAOYSA-N 0.000 description 1
- TWGHMXOYRUTQOL-UHFFFAOYSA-N O-Methylconfusameline Natural products COC1=C2C=COC2=NC2=CC(OC)=CC=C21 TWGHMXOYRUTQOL-UHFFFAOYSA-N 0.000 description 1
- QJXWUIMKPMYBBA-UHFFFAOYSA-N OC1=C(C(=C(C=2C(C3=CC=CC=C3C(C12)=O)=O)C)OCC)O.OC1=C(C(=CC=2C(C3=CC=CC=C3C(C12)=O)=O)O)C Chemical compound OC1=C(C(=C(C=2C(C3=CC=CC=C3C(C12)=O)=O)C)OCC)O.OC1=C(C(=CC=2C(C3=CC=CC=C3C(C12)=O)=O)O)C QJXWUIMKPMYBBA-UHFFFAOYSA-N 0.000 description 1
- MAYJEFRPIKEYBL-OASIGRBWSA-N Obacunone Chemical compound C=1([C@@H]2OC(=O)[C@H]3O[C@@]43[C@]3(C)C(=O)C[C@H]5C(C)(C)OC(=O)C=C[C@]5(C)[C@H]3CC[C@]42C)C=COC=1 MAYJEFRPIKEYBL-OASIGRBWSA-N 0.000 description 1
- MGJLSBDCWOSMHL-WFMNFSIZSA-N Ononin Natural products O(C)c1ccc(C=2C(=O)c3c(OC=2)cc(O[C@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O2)cc3)cc1 MGJLSBDCWOSMHL-WFMNFSIZSA-N 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 241000382362 Persicaria tinctoria Species 0.000 description 1
- 241000244269 Peucedanum Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- INYYVPJSBIVGPH-QHRIQVFBSA-N Sinomenine Chemical compound C([C@@H]1N(CC2)C)C3=CC=C(OC)C(O)=C3[C@@]32[C@@H]1C=C(OC)C(=O)C3 INYYVPJSBIVGPH-QHRIQVFBSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 241001593750 Turcica Species 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- WNFXUXZJJKTDOZ-HNNXBMFYSA-N [(1s)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] acetate Chemical compound C1=CC(O)=C2C(=O)C([C@@H](OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-HNNXBMFYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- ZRNARVWAJZIBTH-UHFFFAOYSA-N afromosin Natural products O1C=CC(=O)C2=C1C=C(O)C(OC)=C2 ZRNARVWAJZIBTH-UHFFFAOYSA-N 0.000 description 1
- QQUHMASGPODSIW-ICECTASOSA-N albiflorin Chemical compound O([C@@]12C[C@H]3[C@H](O)C[C@@]1(OC(=O)[C@]32COC(=O)C=1C=CC=CC=1)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QQUHMASGPODSIW-ICECTASOSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 description 1
- VIWQCBZFJFSCLC-UHFFFAOYSA-N alpha-benzoyloxypaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=C(O)C=C1 VIWQCBZFJFSCLC-UHFFFAOYSA-N 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- GLYPKDKODVRYGP-UHFFFAOYSA-O berberrubine Natural products C1=C2CC[N+]3=CC4=C(O)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 GLYPKDKODVRYGP-UHFFFAOYSA-O 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- GLYPKDKODVRYGP-UHFFFAOYSA-N burberrubine Natural products C12=CC=3OCOC=3C=C2CCN2C1=CC1=CC=C(OC)C(=O)C1=C2 GLYPKDKODVRYGP-UHFFFAOYSA-N 0.000 description 1
- AYMYWHCQALZEGT-ORCRQEGFSA-N butein Chemical class OC1=CC(O)=CC=C1C(=O)\C=C\C1=CC=C(O)C(O)=C1 AYMYWHCQALZEGT-ORCRQEGFSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical group [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- YYFOFDHQVIODOQ-UHFFFAOYSA-O columbamine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)O)OC)CC3)[N+]3=CC2=C1OC YYFOFDHQVIODOQ-UHFFFAOYSA-O 0.000 description 1
- CYOURJWVXZHEPP-UHFFFAOYSA-N columbamine Natural products COc1cc2CCN3Cc4c(OC)c(OC)ccc4C=C3c2cc1O CYOURJWVXZHEPP-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- XYHOBCMEDLZUMP-UHFFFAOYSA-N coptisine Chemical compound C1=C2C=C(C3=C(C=C4OCOC4=C3)CC3)[N+]3=CC2=C2OCOC2=C1 XYHOBCMEDLZUMP-UHFFFAOYSA-N 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical compound [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- XCDQFROEGGNAER-PFOIMGGJSA-N epi-Friedelanol Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3CC[C@H](O)[C@@H]1C XCDQFROEGGNAER-PFOIMGGJSA-N 0.000 description 1
- FPJQGFLUORYYPE-UHFFFAOYSA-N epiberberine Chemical compound C1=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C2OCOC2=C1 FPJQGFLUORYYPE-UHFFFAOYSA-N 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- FWTBRZMBHIYQSW-UHFFFAOYSA-N epifriedelanol Natural products CC1C(O)C(O)CC2C1(C)CCC3C2(C)CCC4(C)C5CC(C)(C)CCC5(C)C(O)CC34C FWTBRZMBHIYQSW-UHFFFAOYSA-N 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 150000007946 flavonol Chemical class 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- HKQYGTCOTHHOMP-UHFFFAOYSA-N formononetin Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O HKQYGTCOTHHOMP-UHFFFAOYSA-N 0.000 description 1
- CXQMYXUCGMYFCD-UHFFFAOYSA-N furanocoumarin glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1=C(OC=C2)C2=CC2=C1OC(=O)C=C2 CXQMYXUCGMYFCD-UHFFFAOYSA-N 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- DOMJKIVDRZSIJN-UHFFFAOYSA-N kokusaginine Natural products COC12Cc3ncccc3CC1(OC)C=CO2 DOMJKIVDRZSIJN-UHFFFAOYSA-N 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- AGRYIZUKIKYUFX-DNITZUGTSA-N lactiflorin Chemical compound C([C@@]12[C@]34C[C@H]2C(=O)C[C@H]1O[C@@]3(O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O4)C)OC(=O)C1=CC=CC=C1 AGRYIZUKIKYUFX-DNITZUGTSA-N 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical class [H]C([H])([H])* 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- VSLDMVSILHVDSR-UHFFFAOYSA-N obacunone Natural products CC1(C)OC(=O)C=CC2(C)C1CC(=O)C3(C)C2CCC4(C)C(OC(=O)C5OC345)c6occc6 VSLDMVSILHVDSR-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- MGJLSBDCWOSMHL-MIUGBVLSSA-N ononin Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=C2C1=O MGJLSBDCWOSMHL-MIUGBVLSSA-N 0.000 description 1
- MGJLSBDCWOSMHL-UHFFFAOYSA-N ononoside Natural products C1=CC(OC)=CC=C1C1=COC2=CC(OC3C(C(O)C(O)C(CO)O3)O)=CC=C2C1=O MGJLSBDCWOSMHL-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 1
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 229910052957 realgar Inorganic materials 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- WNFXUXZJJKTDOZ-UHFFFAOYSA-N shikonin acetate Natural products C1=CC(O)=C2C(=O)C(C(OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-UHFFFAOYSA-N 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- SACPYSHBQFRBLR-UHFFFAOYSA-N skimmianine Natural products COC1=C2C=COC2Nc3c(OC)c(OC)ccc13 SACPYSHBQFRBLR-UHFFFAOYSA-N 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗烧烫伤的外用中药组合物，该组合物各原料药及其重量配比为：大黄：20-60份，黄芩：10-60份，龙血竭2-40份，血余炭5-20份，棕榈炭10-30份，青黛5-15份，冰片2-10份，生石灰2-13份，黄连10-50份，当归5-40份，白芷5-20份，甘草2-15份，紫草2-10份，血见愁5-60份，朱砂1-6份，马勃2-10份，鸡血藤5-20份，白芍2-20份。本发明治疗烧烫伤可有效抑制创面渗出，减少组织液的丢失，干性环境不利细菌生长，且诸药有抗炎抑菌作用，可减少感染机会。本发明克服了现有治疗大面积烧烫伤需植皮而无供皮区的不足，能使烧烫伤创面再生皮肤结痂愈合，治愈率在94%以上。
Description
技术领域：
本发明涉及一种外用中药组合物，具体说是一种治疗烧烫伤的外用中药组合物。
背景技术：
烧烫伤在日常劳动中常见，它包括火焰、蒸汽、热水、热汤、强酸、强碱、高压电等引起的损伤。严重的烧伤不仅损伤皮肤，还可深达肌肉、骨骼甚至引起全身变化，危及生命。烧伤创面大都出现组织液的大量渗出，创面经久不愈，感染常见。因此，减少渗出、修复皮损是治疗烧伤的关键。
发明内容
本发明的目的在于克服现有治疗大面积烧烫伤需植皮而无供皮区的不足，提供一种能使烧烫伤创面再生皮肤结痂愈合的外用中药组合物。
所采用的技术方案为：一种治疗烧烫伤的外用中药组合物，该组合物各原料药及其重量配比为：大黄：20-60份，黄芩：10-60份，龙血竭2-40份，血余炭5-20份，棕榈炭10-30份，青黛5-15份，冰片2-10份，生石灰2-13份，黄连10-50份，当归5-40份，白芷5-20份，甘草2-15份，紫草2-10份，血见愁5-60份，朱砂1-6份，马勃2-10份，鸡血藤5-20份，白芍2-20份。
本发明中各原料药机理：
大黄：苦、寒，归大肠、脾、胃、心、肝经。《本草纲目》：“主治实热燥结，潮热谵语，诸火疮”。化学成分及药理作用：本品主含蒽醌类衍生物，并含瑟酮类、芪苷类、萘酚类、多糖化合物等，本品有泻下、解热、镇痛，改善微循环，止血，抑菌、消炎作用。
黄芩：苦、寒。归肺、胃、肝、胆、大肠、膀胱经。主治：清热解毒，泻火，凉血止血。化学成分及药理作用;本品含有黄酮类化合物，并含有苯乙醇糖苷、苯甲酸、β谷甾醇、氨基酸、糖类等。在体外对多种致病菌、流感病毒、钩端螺旋体均有较强的抑制作用，能抑制被动皮肤过敏反应。
血竭：辛、咸，平。归心、肝经。《新修本草》：“心腹卒痛，金疮出血，破积血，止痛。生肉”，具有活血止痛、化瘀止血，生肌敛疮的作用，化学成分及药理作用：本品主要为一种树脂酯及血竭树脂鞣醇的混合物，并含有松香酸，苯甲酸等，对多种致病真菌有不同程度的抑制作用。
血余炭：苦、微温。消瘀，止血，利小便。.《医学衷中参西录》：“血余者，发也，不煅则其质不化，故必煅为炭然后入药。其性能化瘀血、生新血有似三七，故善治吐血、衄血。而常服之又可治劳瘵，因劳瘵之人，其血必虚而且瘀，故《金匮》谓之血痹虚劳。”主要成分：血余中的主要成分为一种优角蛋白，含水分１２％～１５％，灰分０.３%，脂肪３.４％～５.８％，氮１７.４％，硫５.００％，亦含黑色素．灰分中含有金属（按含量多少）依次为： 钙＞钠＞钾＞锌＞铜＞铁＞锰＞砷．现代研究表明血余炭具有止血和抗菌功能。
棕榈炭：苦、涩，平。归肝、肺、大肠经。功效：收敛止血。《本草拾遗》：“烧作灰，主破血止血。”化学成分：本品含有大量纤维及鞣质，并含有较丰富的金属元素锌、铁、铜、锰。药理作用：棕榈子粉的醇提取物能收缩子宫，并有一定的凝血作用。
青黛：味咸、性寒，功效：清热解毒，凉血止血，清肝泻火。《开宝本草》：主解诸药毒，小儿诸热，惊厥发热，天行头痛寒热，煎水研服之。亦摩敷热疮、恶肿、金疮、下血、蛇犬等毒。成分：从马蓝制得的青黛中分得：靛玉红，靛蓝，异靛蓝。
从蓼蓝制得的青黛中分得靛玉红，靛蓝，N-苯基-2-荼胺，β-谷甾醇，虫漆蜡醇，靛甙，松蓝甙B，色氨酮，青黛酮。从木蓝制得的青黛中分昨：靛玉红。从菘蓝制得的青黛中分得：靛玉红，靛蓝，色氨酮，青黛酮，靛红，正二十九烷。现代研究表明青黛具有抗肿瘤、抑菌作用。
当归：《神农本草经》：甘、辛、温。归肝、心、脾、大肠经。《本草纲目》“润肠胃筋骨皮肤，治痈疽，排脓止痛，和血补血”。化学成分及药理作用：本品富含挥发性成分、有机酸、糖类、维生素、氨基酸、无机元素、碱性成分及豆甾醇、谷甾醇等成分，具有促进血红蛋白及红细胞的生成，缓解外周血管平滑肌筋挛，增加血流量，改善外周循环，抗血栓，镇痛，消炎，增强免疫功能。
白芷：味辛，性温，功效：祛风除湿，通窃止痛，消肿排脓。本经》：主女人漏下赤白，血闭阴肿，寒热，风头（头风)侵目泪出，长肌肤，润泽。成分：根含香豆精类：欧前胡内酯，异欧前胡内酯，氧化前胡内酯，水合氧化前胡内酯[5]，珊瑚菜素，白当归素及叔-O-甲基白当归素等；香豆精葡萄糖甙类；紫花前胡甙，3-羟基印度榲楟甙，白当归素-叔-O-β-D-吡喃葡萄糖甙，白当归素-仲-O-β-D-吡喃葡萄糖甙，东莨菪甙，茵芋甙，花椒毒酚-8-O-β-D-吡喃葡萄糖甙，独活属醇-叔-O-β-D-吡喃葡萄糖甙等，另含腺甙。 现代研究表明白芷具有抗炎、抑菌作用。
冰片：味辛，苦，性凉，功效：开窍醒神，散热止痛，明目去翳。成分：冰片为右旋龙脑，现代研究表明冰片就有抗炎抑菌作用。
生石灰：辛、苦、涩、温，有毒。功效：解毒蚀腐，敛疮止血，杀虫止痒。成分：生石灰为氧化钙,熟石灰为氢氧化钙。
黄连：苦，寒。功效：清热泻火、燥湿、解毒。成分：黄连根茎含小檗碱5. 56％-7.25％，黄连碱，表小檗碱，小檗红碱，掌叶防已碱，非洲防己碱，药根碱，甲基黄连碱，木兰花减，阿魏酸，黄柏酮，黄柏内酯。主治：热毒疮疡、疔毒走黄、牙龈肿痛、口舌生疮、聤耳、阴肿、痔血、湿疹、烫伤。
甘草：甘、平，功效：和中缓急，润肺，解毒，调和诸药。成分：根及根茎含甘草甜素，为甘草酸的钾、钙盐。尚含甘草甙、甘草甙元、异甘草甙、异甘草元、新甘草甙、新异甘草甙等。
紫草：性寒，味甘、咸。功能主治 ：凉血活血，解毒透疹。用于血热毒盛、斑疹紫黑、麻疹不透、疮疡、湿疹、水火烫伤。清热凉血，用于麻疹，热病癍疹，湿疹，尿血，血淋，血痢，疮疡，丹毒，烧伤，热结便秘。有效成分：含乙酰紫草素、β-羟基异戊酰紫草素、紫草素、β，β’-二甲基丙烯酰紫草素。
血见愁：苦、寒，归肝心经，功效：凉血止血，活血化瘀 。成分：茜草根含蒽醌衍生物茜草素，羟基茜草素，异茜草素，1-羟基-2-甲基蒽醌，1， 4二羟基-6-甲基蒽醌，去甲虎刺醛，大黄素甲醚，1-羟基 2-甲氧基蒽醌，1，4二羟基 2-甲基-5-(或8)-甲氧基蒽醌，1，3-二甲氧基-2-梭基蒽醌，1， 3-二羟基-2-甲基蒽醌二羟基-2-乙氧基甲基蒽醌。
朱砂：甘、凉，有毒，功效：镇心安神，清热解毒，明目。成分：朱砂主要成分为硫化汞，含汞量85.41%，但常混有雄黄、磷灰石、沥青等杂质。
鸡血藤：味苦、微甘、性温 ，《饮片新参》：去瘀血，生新血，流利经脉。治暑痧，风血痹症。主要成分：藤茎含表无羁萜醇，胡萝卜甙，β-谷甾醇，7-酮基-β-谷甾醇，刺芒柄花素，芒柄花甙，樱黄素，阿佛洛莫生，大豆素，3，7-二羟基-6-甲氧基二氢黄酮醇，表儿茶精，异甘草甙元，3，4，2’，4’-四羟基查耳酮（3，4，2’，4’，甘草查耳酮A，苜猪酚，原儿茶酸，9-甲氧基香豆雌酚，木豆异黄酮。鸡血藤甘温，长于补血，温经活络，伤家常用。现代研究鸡血藤对凝血、纤溶有很好的作用。
马勃：辛，性平，主治：咽喉肿痛，咳嗽失音，吐血衄血，诸疮不敛。.《本草从新》：每见用寒凉药敷疮者，虽愈而热毒内攻，变生他病，为害不小，惟马勃辛平而散，甚为稳妥。成分：紫色秃马勃子实体马勃菌酸。大秃马勃子实体含α-淀粉酶及多种氢基酸。头状秃马勃子实体含马勃菌酸。网纹马勃子实体含网纹马勃酸,蛋白质31.7%,黑色素,脂肪酸,芳香酸.梨形马勃子实体含马勃菌酸，马勃菌酸甲酯，苯甲酸。
白芍：苦寒，功效：养血和营，缓急止痛，敛阴平肝。成分：根含芍药甙,氧化芍药甙，苯甲酰芍药甙，白芍甙，芍药甙无酮，没食子酰芍药甙，β-蒎-10-烯基-β-巢菜甙，芍药新甙，芍药内酯A、B、C，β-谷甾醇，胡萝卜甙。还从根的鞣质中分得1，2，3，6-四没食子酰基葡萄糖，1,2,3,4,6-五没食子酰基葡萄糖及相应的六没食子酰基葡萄糖和七没食子酰基葡萄糖等。又含右旋儿茶精及挥发油。挥发油主要含苯甲酸,牡丹酚及其他醇类和酚类成分共33个。
以上原料均可自普通药店购买到，其规格符合国家医药标准。
本发明治疗烧烫伤可有效抑制创面渗出，减少组织液的丢失，干性环境不利细菌生长，且诸药有抗炎抑菌作用，可减少感染机会，其中当归可以缓解外周血管平滑肌筋挛，增加血流量，改善外周循环，抗血栓，促进创面愈合，并有镇痛，消炎作用，黄连中的小檗碱具有很好的镇痛作用。而且创面应用本发明后如果患者创面干操则不需换药，减少换药次数，缩短创面愈合时间。本发明克服了现有治疗大面积烧烫伤需植皮而无供皮区的不足，能使烧烫伤创面再生皮肤结痂愈合，效果肯定，得到了患者认可，治愈率在94%以上。本发明有关治疗情况如下：
1、病人概况：选择病史、病情、年龄、性别及原始治疗方法等项。106例患者烧烫伤病史最长1月，最短1天；烧伤创面65%1例，烧烫伤面积30%—40%23例，烧烫伤面积20%-30%36例，烧烫伤面积20%以下56例，以上病例烧烫伤程度均为深二度至三度，其中男性56例，女性50例；年龄最大72岁，最小1岁。以上病例在未用前均用湿润烧伤膏治疗，其中痂下积脓39例，经切痂用本物治疗后痊愈。
2、用法用量：彻底清创后外涂本粉剂适量，创面干燥者不需处理；创面有渗出者，清创后可重新涂用本物致干燥结痂，烧焦部位可将本粉制成膏剂涂用，直至自行结痂脱落。
3、疗效分析：一般病人用药3-5次后均创面干燥无渗出，疼痛即可明显缓解，十五天左右可见部分创面结痂脱落。脱落处均无明显疤痕增生，经一至两个疗程治疗后106例患者中创面结痂痊愈100例，好转6例。
疗效标准：（中医药烧伤治疗学 丁宝财著 辽宁科学技术出版社）
治愈：a、烧伤创面基本消灭（大面积烧伤时散在小创面不足0.5%）。
b、病人全身情况明显好转，无严重烧伤并发症（如败血症、肺炎）。
好转：a、病人情况明显好转（如休克以纠正），无严重并发症。
b、烧伤创面大部分消灭。
4、不良反应：个别患者用药后感觉患部烧灼不适，一般不需治疗，症状可自行消失。
本发明物小儿及孕产妇用药未见明显副作用。
具体实施方式
实施例1，一种治疗烧烫伤的外用中药组合物，该组合物各原料药及其重量配比为：大黄40份，黄芩40份，龙血竭35份，血余炭15份，棕榈炭15份，青黛10份，冰片5份，生石灰10份，黄连40份，当归40份，白芷20份，甘草10份，紫草10份，血见愁60份，朱砂5份，马勃5份，鸡血藤10份，白芍15份。
实施例2，一种治疗烧烫伤的外用中药组合物，该组合物各原料药及其重量配比为：大黄20份，黄芩60份，龙血竭2份，血余炭20份，棕榈炭25份，青黛8份，冰片5份，生石灰5份，黄连45份，当归10份，白芷20份，甘草2份，紫草10份，血见愁5份，朱砂6份，马勃2份，鸡血藤20份，白芍2份。
实施例3，一种治疗烧烫伤的外用中药组合物，该组合物各原料药及其重量配比为：大黄30份，黄芩50份，龙血竭10份，血余炭15份，棕榈炭20份，青黛12份，冰片4份，生石灰10份，黄连20份，当归45份，白芷10份，甘草8份，紫草5份，血见愁40份，朱砂2份，马勃5份，鸡血藤8份，白芍12份。
实施例4，一种治疗烧烫伤的外用中药组合物，该组合物各原料药及其重量配比为：大黄50份，黄芩20份，龙血竭25份，血余炭10份，棕榈炭30份，青黛5份，冰片10份，生石灰2份，黄连50份，当归5份，白芷15份，甘草5份，紫草8份，血见愁30份，朱砂3份，马勃3份，鸡血藤15份，白芍10份。
实施例5，一种治疗烧烫伤的外用中药组合物，该组合物各原料药及其重量配比为：大黄60份，黄芩10份，龙血竭40份，血余炭5份，棕榈炭10份，青黛15份，冰片2份，生石灰13份，黄连10份，当归50份，白芷5份，甘草15份，紫草2份，血见愁50份，朱砂1份，马勃10份，鸡血藤5份，白芍20份。
将上述实施例按比例配合后，按本技术领域的惯常作法可制成粉剂或膏剂，每次涂撒本发明适量，至创面干燥无渗出，一般病人用药1-3次疼痛即可明显缓解，创面干燥无渗出。半月到一月创面可结痂愈合。而且疤痕小。
Claims (4)
1.一种治疗烧烫伤的外用中药组合物，其特征在于：该组合物各原料药及其重量配比为：大黄：20-60份，黄芩：10-60份，龙血竭2-40份，血余炭5-20份，棕榈炭10-30份，青黛5-15份，冰片2-10份，生石灰2-13份，黄连10-50份，当归5- 50份，白芷5-20份，甘草2-15份，紫草2-10份，血见愁5-60份，朱砂1-6份，马勃2-10份，鸡血藤5-20份，白芍2-20份。
2.根据权利要求1所述的一种治疗烧烫伤的外用中药组合物，其特征在于：该组合物各原料药及其重量配比为：大黄：30-50份，黄芩：20-50份，龙血竭10-35份，血余炭 5-15份，棕榈炭10-20份，青黛5-10份，冰片2-5份，生石灰2-10份，黄连20-45份，当归10-45份，白芷5-20份，甘草2-10份，紫草2-10份，血见愁5-60份，朱砂1-6份，马勃2-5份，鸡血藤5-10份，白芍2-15份。
3.根据权利要求1所述的一种治疗烧烫伤的外用中药组合物，其特征在于：该组合物各原料药及其重量配比为：大黄：40，黄芩：40，龙血竭35，血余炭15份，棕榈炭15份，青黛10份，冰片5份，生石灰10份，黄连40份，当归40份，白芷20份，甘草10份，紫草10份，血见愁60份，朱砂5份，马勃5份，鸡血藤10份，白芍15份。
4.根据权力要求1至3中任一项所述的一种治疗烧烫伤疾病的外用中药组合物，其特征在于：该组合物可制成粉剂或就粉剂制成膏剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100630469A CN102579763B (zh) | 2012-03-12 | 2012-03-12 | 治疗烧烫伤的外用中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100630469A CN102579763B (zh) | 2012-03-12 | 2012-03-12 | 治疗烧烫伤的外用中药组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102579763A true CN102579763A (zh) | 2012-07-18 |
| CN102579763B CN102579763B (zh) | 2013-11-13 |
Family
ID=46469365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012100630469A Expired - Fee Related CN102579763B (zh) | 2012-03-12 | 2012-03-12 | 治疗烧烫伤的外用中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102579763B (zh) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103028044A (zh) * | 2012-12-08 | 2013-04-10 | 浙江大学 | 一种治疗烧烫伤的膏剂 |
| CN103948815A (zh) * | 2014-05-20 | 2014-07-30 | 张继超 | 一种植皮术后局部熏蒸的药物组合物 |
| CN105233261A (zh) * | 2015-11-18 | 2016-01-13 | 桂林华诺威基因药业有限公司 | 一种能促进骨科手术切口愈合的组合物 |
| CN105233266A (zh) * | 2015-11-18 | 2016-01-13 | 桂林华诺威基因药业有限公司 | 一种能促进创伤愈合的喷剂 |
| CN105233262A (zh) * | 2015-11-18 | 2016-01-13 | 桂林华诺威基因药业有限公司 | 一种能促进创伤愈合的药膏 |
| CN105233265A (zh) * | 2015-11-18 | 2016-01-13 | 桂林华诺威基因药业有限公司 | 一种能促进创伤愈合的组合物 |
| CN105233267A (zh) * | 2015-11-18 | 2016-01-13 | 桂林华诺威基因药业有限公司 | 用于美容术后创面修复的组合物 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1207318A (zh) * | 1998-08-13 | 1999-02-10 | 王新民 | 一种治疗烧伤烫伤的外用药膏 |
| CN101108238A (zh) * | 2007-07-16 | 2008-01-23 | 李芬 | 烧伤生肌油及其制备方法 |
| CN101658609A (zh) * | 2009-09-16 | 2010-03-03 | 白瑞 | 一种拔毒生肌药及其制备方法 |
-
2012
- 2012-03-12 CN CN2012100630469A patent/CN102579763B/zh not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1207318A (zh) * | 1998-08-13 | 1999-02-10 | 王新民 | 一种治疗烧伤烫伤的外用药膏 |
| CN101108238A (zh) * | 2007-07-16 | 2008-01-23 | 李芬 | 烧伤生肌油及其制备方法 |
| CN101658609A (zh) * | 2009-09-16 | 2010-03-03 | 白瑞 | 一种拔毒生肌药及其制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| 韦东: "中医药治疗烧伤的研究及其进展", 《辽宁中医学院学报》 * |
| 黄泉洲: "简易烧伤膏临床运用", 《湖北中医杂志》 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103028044A (zh) * | 2012-12-08 | 2013-04-10 | 浙江大学 | 一种治疗烧烫伤的膏剂 |
| CN103028044B (zh) * | 2012-12-08 | 2014-07-16 | 浙江大学 | 一种治疗烧烫伤的膏剂 |
| CN103948815A (zh) * | 2014-05-20 | 2014-07-30 | 张继超 | 一种植皮术后局部熏蒸的药物组合物 |
| CN105233261A (zh) * | 2015-11-18 | 2016-01-13 | 桂林华诺威基因药业有限公司 | 一种能促进骨科手术切口愈合的组合物 |
| CN105233266A (zh) * | 2015-11-18 | 2016-01-13 | 桂林华诺威基因药业有限公司 | 一种能促进创伤愈合的喷剂 |
| CN105233262A (zh) * | 2015-11-18 | 2016-01-13 | 桂林华诺威基因药业有限公司 | 一种能促进创伤愈合的药膏 |
| CN105233265A (zh) * | 2015-11-18 | 2016-01-13 | 桂林华诺威基因药业有限公司 | 一种能促进创伤愈合的组合物 |
| CN105233267A (zh) * | 2015-11-18 | 2016-01-13 | 桂林华诺威基因药业有限公司 | 用于美容术后创面修复的组合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102579763B (zh) | 2013-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102579763B (zh) | 治疗烧烫伤的外用中药组合物 | |
| CN105833279B (zh) | 皮肤多种损伤创面治疗的外用药物组合物及其制备方法 | |
| CN102205024A (zh) | 一种治疗烧伤药膏及其制备方法 | |
| CN102475813A (zh) | 一种治疗湿疹的药物 | |
| CN104208245B (zh) | 手足癣中药药浴及制备方法 | |
| CN103520381B (zh) | 一种去脚气足浴粉及其制备方法 | |
| CN100548334C (zh) | 生皮愈疡膏（愈疡胶囊）及其制作工艺 | |
| CN104940886A (zh) | 一种治疗脂溢性脱发的外用制剂及制法 | |
| CN104740211A (zh) | 一种治疗下肢静脉曲张的中药组合物及其制备方法 | |
| CN105250525A (zh) | 一种治疗糖尿病足的中药洗剂及其制备方法 | |
| CN102284006B (zh) | 一种治疗褥疮及烧烫创伤的外用膏剂 | |
| CN105561098A (zh) | 一种治疗糜烂性脚气的药物 | |
| CN105616536A (zh) | 一种治疗白癜风的中药擦剂 | |
| CN101336985B (zh) | 一种止痛止痒药酒及其制备方法 | |
| CN109045204A (zh) | 一种治疗烧伤和烫伤的中药液及其制备方法 | |
| CN105687938A (zh) | 一种用于肛裂的中药制剂及其制备方法 | |
| CN101401881B (zh) | 一种治疗蛊毒的中药组合物 | |
| CN105362944A (zh) | 一种治疗骨科扭挫伤的中药膏剂 | |
| CN105560582A (zh) | 治疗冻疮的消肿止痒药膏及制法 | |
| CN105381366A (zh) | 一种治疗褥疮的中药组合物及其制备方法 | |
| CN104784666A (zh) | 一种骨科护理用中药药膏 | |
| CN117281854A (zh) | 疤痕软散液及其制备方法 | |
| CN102000252B (zh) | 一种治疗血瘤的药及其制备方法 | |
| CN104666541A (zh) | 一种治疗急性典型阿米巴肠病的中药 | |
| CN108186952A (zh) | 一种用于防治家兔湿疹的中草药洗液及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131113 |